Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease
DH Au, CL Bryson, VS Fan, EM Udris, JR Curtis… - The American journal of …, 2004 - Elsevier
PURPOSE: To assess the association between the type of antihypertensive medication and
all-cause mortality among patients with chronic obstructive pulmonary disease (COPD).
METHODS: The cohort comprised 1966 patients (mean [±SD] age, 65.8±10.7 years)
enrolled in general internal medicine clinics at seven Veterans Affairs medical centers
between December 1996 and October 1999. Patients had a diagnosis of both COPD and
hypertension and were receiving single-agent antihypertensive therapy. RESULTS …
all-cause mortality among patients with chronic obstructive pulmonary disease (COPD).
METHODS: The cohort comprised 1966 patients (mean [±SD] age, 65.8±10.7 years)
enrolled in general internal medicine clinics at seven Veterans Affairs medical centers
between December 1996 and October 1999. Patients had a diagnosis of both COPD and
hypertension and were receiving single-agent antihypertensive therapy. RESULTS …